Dashboard
Manage Tickers

CORT


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

canaccord-genuity-maintains-buy-on-corcept-therapeutics-raises-price-target-to-78
Canaccord Genuity Maintains Buy on Corcept...
07/31/2024 12:33:19

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target fr...

canaccord-genuity-maintains-buy-on-corcept-therapeutics-maintains-38-price-target
Canaccord Genuity Maintains Buy on Corcept...
07/30/2024 15:28:33

Canaccord Genuity analyst Edward Nash maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $38 price target.

unveiling-8-analyst-insights-on-corcept-therapeutics
Unveiling 8 Analyst Insights On Corcept Th...
07/30/2024 12:00:32

corcept-therapeutics-shares-are-trading-higher-after-the-company-reported-better-than-expected-q2-financial-results-and-raised-its-fy24-revenue-guidance-above-estimates-also-hc-wainwright--co-and-piper-sandler-raised-their-respective-price-targets-on-the-stock
Corcept Therapeutics shares are trading hi...
07/30/2024 11:45:17

piper-sandler-maintains-overweight-on-corcept-therapeutics-raises-price-target-to-38
Piper Sandler Maintains Overweight on Corc...
07/30/2024 11:19:19

Piper Sandler analyst David Amsellem maintains Corcept Therapeutics (NASDAQ:CORT) with a Overweight and raises the price tar...

hc-wainwright--co-maintains-buy-on-corcept-therapeutics-raises-price-target-to-45
HC Wainwright & Co. Maintains Buy on Corce...
07/30/2024 10:40:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises th...

corcept-therapeutics-raises-2024-revenue-guidance-from-620m650m-to-640m670m-vs-63215m-est
Corcept Therapeutics Raises 2024 Revenue G...
07/29/2024 20:13:16

corcept-therapeutics-q2-2024-gaap-eps-032-beats-023-estimate-sales-163800m-beat-155226m-estimate
Corcept Therapeutics Q2 2024 GAAP EPS $0.3...
07/29/2024 20:12:09

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.32 per share which beat the analyst consensus estimate of ...

piper-sandler-reiterates-overweight-on-corcept-therapeutics-maintains-35-price-target
Piper Sandler Reiterates Overweight on Cor...
07/01/2024 13:44:13

Piper Sandler analyst David Amsellem reiterates Corcept Therapeutics (NASDAQ:CORT) with a Overweight and maintains $35 price...

corcept-therapeutics-announces-results-from-catalyst-clinical-trial-at-adas-84th-scientific-sessions-study-shows-24-prevalence-of-hypercortisolism-in-patients-with-difficult-to-control-type-2-diabetes-largest-study-to-date-with-1055-patients
Corcept Therapeutics Announces Results Fro...
06/24/2024 20:16:59

Results from the CATALYST clinical trial were presented at the American Diabetes Association's 84th Scientific Sessions at ...

6-analysts-have-this-to-say-about-corcept-therapeutics
6 Analysts Have This To Say About Corcept ...
06/17/2024 19:00:59

truist-securities-maintains-buy-on-corcept-therapeutics-maintains-65-price-target
Truist Securities Maintains Buy on Corcept...
06/17/2024 15:27:39

Truist Securities analyst Joon Lee maintains Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintains $65 price target.

concerpt-therapeutics-shares-are-trading-lower-what-you-need-to-know
Concerpt Therapeutics Shares Are Trading L...
06/14/2024 18:54:41

Corcept Therapeutics Inc. (NASDAQ: CORT) shares are trading lower Friday afternoon following a report suggesting Teva Pharmaceu...

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

Core News & Articles
Reported Late Thursday: Teva Sues Corcept ...
06/14/2024 16:31:28

Teva sues Corcept over mifepristone 'monopoly' for rare disorder | Reuters

truist-securities-reiterates-buy-on-corcept-therapeutics-raises-price-target-to-65
Truist Securities Reiterates Buy on Corcep...
06/04/2024 13:22:01

Truist Securities analyst Joon Lee reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and raises the price target from...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/03/2024 17:35:22

corcept-therapeutics-to-present-results-of-phase-3-grace-trial-evaluating-relacorilant-in-patients-with-hypercortisolism-cushings-syndrome-at-endo-2024
Corcept Therapeutics To Present Results Of...
06/03/2024 12:36:13

Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company engaged in the discovery and development of medicat...

corcept-therapeutics-stock-a-deep-dive-into-analyst-perspectives-4-ratings
Corcept Therapeutics Stock: A Deep Dive In...
05/29/2024 13:00:44

hc-wainwright--co-reiterates-buy-on-corcept-therapeutics-maintains-40-price-target
HC Wainwright & Co. Reiterates Buy on Corc...
05/29/2024 10:56:34

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Corcept Therapeutics (NASDAQ:CORT) with a Buy and maintain...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION